Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

p16INK4a monoclonal antibody

Monoclonal antibody to p16 for use with IHC applications
 
ENZ-ABS377-0100 100 µl Inquire for pricing
 
ENZ-ABS377-1000 1 ml Inquire for pricing
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:p16, Cyclin-dependent kinase inhibitor 2A
 
Host:Mouse
 
Isotype:IgG
 
Immunogen:Recombinant p16.
 
UniProt ID:P51480
 
Species reactivity:Human
 
Applications:IHC
 
Recommended Dilutions/Conditions:Immunohistochemistry (1:50-1:100)
Optimal conditions must be determined individually for each application.
 
Application Notes:For IHC applications: Dilute the concentrate as appropriate in Antibody Blocking Buffer (ENZ-ACC108), and then apply 150 µL to the slide, as indicated in the user's IHC protocol.
 
Purity Detail:Affinity-purified.
 
Formulation:Liquid. In Tris buffer, pH 7.5, containing 1% BSA and <0.1% sodium azide.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Shipped on Blue Ice
 
Short Term Storage:+4°C
 
Long Term Storage:+4°C
 
ENZ-ABS377 2
Cervical tissue incubated with p16INK4a monoclonal antibody (ENZ-ABS377) and then stained with POLYVIEW® PLUS (anti-Mouse) HRP-DAB Kit (ENZ-KIT160).
Please mouse over
ENZ-ABS377 2

Related Products

Antibody Blocker/Diluent 

Ready-to-use antibody blocking buffer and diluent, for use with POLYVIEW® PLUS detection reagents
IHC, ISH (in situ hybridization) | Print as PDF
 
ENZ-ACC108-0100 100 ml Inquire for pricing
Do you need bulk/larger quantities?
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
p16
By biological activity:
p16 Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Product Flyers
p16 Antibody
p16 Antibody
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,